Determination of captopril in human plasma, using solid phase extraction and high-performance liquid chromatography, coupled to mass spectrometry: Application to bioequivalence study

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 850, Issue 1-2, 2007, Pages 59-67

  Rezende, Kênnia R ^b   Mundim, Iram M ^a   Teixeira, Leonardo S ^a   Souza, Weidson C ^a   Ramos, Douglas R ^a   Cardoso, Cláudio R F ^a   Souza, Inácia C ^a   Gratão, Mário Z ^a   Bellório, Karini B ^a  

^a ICF   (Brazil)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

Bioequivalence; Captopril; LC MS; Pharmacokinetics; SPE; Stability validation

Indexed keywords

EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PHARMACOKINETICS; PLASMA (HUMAN);

BIOEQUIVALENCE; CAPTOPRYL; CONCENTRATION RANGE; STABILITY VALIDATION;

DRUG PRODUCTS;

CAPTOPRIL; ENALAPRIL MALEATE;

ARTICLE; BIOEQUIVALENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SOLID PHASE EXTRACTION; TABLET FORMULATION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALIBRATION; CAPTOPRIL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; THERAPEUTIC EQUIVALENCY;

EID: 34247548729     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2006.11.007     Document Type: Article

References (15)

1. Klein J., Colin P., Scherer E., Levy M., and Koren G. Ther. Drug Monit. 12 (1990) 105
2. Duchin K.L., McKinstry D.N., Cohen A.I., and Migdalof B.H. Clin. Pharmacokinet. 14 (1988) 241
3. Arroyo C., Lopez-Calull C., Garcia-Capdevila L., Gich I., Barbanoj M., and Bonal J. J. Chromatogr. B Biomed. Sci. Appl. 688 (1997) 339
4. Franklin M.E., Addison R.S., Baker P.V., and Hooper W.D. J. Chromatogr. B Biomed. Sci. Appl. 705 (1998) 47
5. Bahmaei M., Khosravi A., Zamiri C., Massoumi A., and Mahmoudian M. J. Pharm. Biomed. Anal. 15 (1997) 1181
6. Huang Y.B., Tsai Y.H., Chang J.S., Liu J.C., Tsai M.J., and Wu P.C. Int. J. Pharm. 241 (2002) 345
7. Huang T., He Z., Yang B., Shao L., Zheng X., and Duan G. J. Pharm. Biomed. Anal. (2006)
8. Engalytcheff A., Debuyst R., Vanhaelewyn G.C., Callens F.J., and Tilquin B. Radiat. Res. 162 (2004) 616
9. Tache F., Farca A., Medvedovici A., and David V. J. Pharm. Biomed. Anal. 28 (2002) 549
10. Medvedovici A., Mircioiu C., David V., and Miron D.S. Eur. J. Drug Metab. Pharmacokinet. 25 (2000) 91
11. Kok R.J., Visser J., Moolenaar F., de Zeeuw D., and Meijer D.K. J. Chromatogr. B Biomed. Sci. Appl. 693 (1997) 181
12. Bathala M.S., Weinstein S.H., Meeker Jr. F.S., Singhvi S.M., and Migdalof B.H. J. Pharm. Sci. 73 (1984) 340
13. Salem I.I., Saif W.A., Jmeian Y., and Al Tamimi J.I. J. Pharm. Biomed. Anal. 37 (2005) 1073
14. ANVISA, D.O.U., Diário Oficial da União, Poder Executivo, 02 de junho de 2003. Guia para validação de métodos analíticos e bioanalíticos, 2003.
15. FDA, Center for Drug Evaluation and Research, U S Department of Health and Human Services, Guidance for Industry, Bionalytical Method Validation, 2001.